ReShape Lifesciences Inc. - FORM 10-K - EX-23.1 - CONSENT OF DELOITTE & TOUCHE LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - March 7, 2011

Attached files

file filename
EX-32.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 906 - ReShape Lifesciences Inc.dex322.htm
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 - ReShape Lifesciences Inc.dex312.htm
EX-32.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 906 - ReShape Lifesciences Inc.dex321.htm
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 - ReShape Lifesciences Inc.dex311.htm
EX-10.42 - FOURTH AMENDMENT TO LOAN AND SECURITY AGREEMENT - ReShape Lifesciences Inc.dex1042.htm
EX-10.34 - AMENDMENT NO. 2, EFFECTIVE AS OF JANUARY 4, 2011 TO LICENSE AGREEMENT - ReShape Lifesciences Inc.dex1034.htm
EX-10.29 - CONSULTING AGREEMENT, DATED AS OF OCTOBER 1, 2010 - ReShape Lifesciences Inc.dex1029.htm
EX-10.28 - CONSULTING AGREEMENT, DATED AS OF AUGUST 1, 2010 - ReShape Lifesciences Inc.dex1028.htm
10-K - FORM 10-K - ReShape Lifesciences Inc.d10k.htm

EXHIBIT 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in Registration Statement Nos. 333-171244, 333-159592, and 333-149662 on Form S-8 and Registration Statement Nos. 333-171944, 333-166011, and 333-158516 on Form S-3 of our report dated March 7, 2011, relating to the consolidated financial statements of EnteroMedics Inc. and subsidiary (the “Company”) (which report expresses an unqualified opinion and includes an explanatory paragraph relating to the January 1, 2009 adoption of new authoritative accounting guidance regarding the financial reporting for outstanding equity-linked financial instruments), appearing in this Annual Report on Form 10-K of the Company for the year ended December 31, 2010.

 

/S/    DELOITTE & TOUCHE LLP        

Minneapolis, MN

March 7, 2011

ReShape Lifesciences Inc. Reports

Also read